跳至主要内容
临床试验/NCT03454945
NCT03454945Unknown3 期

Efficacy of Doxycycline in the Treatment of Early Stages of Mycosis Fungoides: A Randomized Controlled Trial

Cairo University2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
30
试验地点
2
主要终点
Clinical assessment

研究概览

简要总结

Current study aims at assessing the efficacy of doxycycline as a potential treatment modality for early stages of MF.

详细描述

Objectives

Objective is to evaluate the efficacy of doxycycline in treatment of early stages of mycosis fungoides (IA, IB and IIA) and to assess its apoptotic enhancing effect by studying the expression of BCL2 by the T lymphocytes.

Study Design

Randomized controlled trial

Population of study & disease condition

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (above 18) of either sex with established diagnosis of classic MF

排除标准

  • Any variant of MF other than the classic variant.
  • Advanced stages of classic MF: Stage IIb, III or IV.
  • Pregnant and lactating females.
  • Patients with autoimmune diseases e.g. SLE
  • Patients with solid or hematological malignancies e.g. breast cancer, leukemia, etc.
  • Patients with any contraindications for doxycycline (eg: liver disease, kidney disease, photosensitivity, peptic ulcer or patients receiving systemic retinoids).
  • Patients with any contraindication to phototherapy (eg: any other skin cancers or photosensitivity); or to psoralen (eg: liver disease)

研究组 & 干预措施

Doxycyline

Experimental

Oral Vibramycin antibiotic100 mg capsule every 12 hours for 3 months

干预措施: Vibramycin (Drug)

Doxycyline

Experimental

Oral Vibramycin antibiotic100 mg capsule every 12 hours for 3 months

干预措施: Phototherapy (Device)

Phototherapy

Active Comparator

UVA+ psoralen 3 sessions per week for 3 months

干预措施: Vibramycin (Drug)

Phototherapy

Active Comparator

UVA+ psoralen 3 sessions per week for 3 months

干预措施: Phototherapy (Device)

结局指标

主要结局

Clinical assessment

时间窗: 3 months

Clinical assessment of the extent of the lesions in body surface area

次要结局

  • Pathological assessment(3months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hagar El Sayed

Principle investigator

Cairo University

研究点 (2)

Loading locations...

相似试验